This is a sample guest message. Register a free account today to become a member! Once signed in, you'll be able to participate on this site by adding your own topics and posts, as well as connect with other members through your own private inbox!
Didn’t say you were, actually the opposite. Just saying there’s people making money selling the idea of an unsafe vaccine, too.Lol, neither MAGA or religious but now I can ignore you. Obviously you are too in them feelings to have a conversation with.
Let’s say Hgen gets an EUA for covid. It’s likely but not definite. But say in 6 weeks they get it and cydy is still drifting with no trial results until December? January? What is the point of buying this? Unless they replace Nader, even with positive trial results, is there any chance they get approval?
I hear you, its coming for sure. May not be going all in as soon as it hits, which was my originally plan. Will proceed a little more cautiously, will get a little more money in but for sure, it could be a bigger drop.
Interestingly enough HGEN's market cap is only 10% larger than CYDY. Anyone investing in CYDY here must just hate money.
If all things were equal, which they are not, my belief is that leronlimab is a better drug than lenzilumab and can be used more widely.
Feels like the earliest might not be until late summer and then the obligatory two more weeks.
The resiliency of this stock is sliding away. And nothing on the horizon as far as I can tell. The press releases are having less and less effect. I wonder what the date would be for the BoD review with the 5% of investors?
I bought 10k shares at around 1.80.
And Hgen just passed cydy on the market cap recently too I believe. Like, a month ago.
That’s part of today’s market. Many of the new investors think HGEN is worth more because the price is more. They certainly don’t get the whole dilution = bad so it’s not surprising.
I am much more heavily invested in HGEN but it seems a legit stock is also getting a lot of push back.
I don’t think we are on the same page. All I’m saying is that all the new investors in the market see $20 vs $2 and assume the $20 per share company is worth more, not knowing that the $2 company might have 20x the outstanding shares.
Might as well call us twins. I was planning to take $1600 in cash and burn it in the fireplace on Friday and then burn another $1400 in cash on Saturday.
This stock has bounced back from the abyss before, I think you really underestimate the believers in this drug.
Just kidding although at this point, I think the chance that you get anything out of this stock is very small.
Mutually terminated for failure to primary of secondary endpoints in both trails...But it works.
I guess there is a chance everybody will get their crack at 1.50 tomorrow. Won’t be me.
I get u, I didn't buy until after the split.
Well they don't have anything to distribute in the USA so why keep this open ended.
25800 unexplained deaths/145,000,000 fully vaxxed = .00017 = .017%
I think if we time the low correctly, we should see a bounce when they announce the Brazil trials are a go. This sounds like it may be coming in the next week. Buy for $1.60 and sell for $2.00?
Doesn't sound unreasonable although I personally think it may take more than just announcing the start of the Brazil trial but you could be right.
Nah, a proactive video and the promise of 2 weeks should do the trick. Expect both soon.
I wish just once we would get actual numbers.
This will be a tough nut to crack unless Cytodyn or the FDA can narrow this down to measurable targets for an approval trail.
Very little but I know I heard NP say that they came up with their own way to measure, which can't be good
Pretty sure Nadar leaving would boost the stock. Not sure any medical upsides for this drug.
I know...not too bright.
